Dr. Geoffrey Sklar is the Chief Medical Officer for Chesapeake Urology and United Urology Group. Dr. Sklar is a Volunteer Associate Professor of Urology at the University of Maryland Medical Center, where he previously was Chief of Urology and Residency Director at the University of Maryland Medical Center.
Dr. Sklar is recognized across the Baltimore region as an innovator in urology care, specializing in the diagnosis and treatment of bladder cancer, prostate cancer, kidney cancer, testicular cancer, penile cancer as well as erectile dysfunction and Peyronie’s disease. He is also one of only a few local physicians trained to perform blue light cystoscopy, an innovative, technology-based tool that aids in precise detection and diagnosis of bladder tumors.
Additionally, Dr. Sklar has earned professional accolades for the extensive research he has conducted and published, contributing to the advancement of care for patients with urological malignancies, erectile dysfunction, Peyronie’s disease, transplant ureteral reconstruction, cryosurgery, endoscopy, and benign prostatic hyperplasia (BPH).
Dr. Sklar has been Chief Medical Officer for Chesapeake Urology since 2009. He is a member of the group’s Executive Clinical Team and chairs Chesapeake Urology’s Grand Rounds, the Morbidity and Mortality Committee, and the Multidisciplinary Tumor Board Committee. He also serves as a liaison for the company on medical matters with outside organizations including hospitals and medical insurance groups. His other duties include physician oversight, quality assurance, and risk management.
Dr. Sklar has held several high-level positions with the University of Maryland Baltimore Washington Medical Center including President of the Medical Staff, Chief of Urology, Chief of Urological Oncology, and Assistant Chief of Surgery. He was a member of the MedStar Health Cancer Network and served as the Associate Director of the Weinberg Cancer Institute at MedStar Franklin Square Medical Center as well as the medical center’s Chief of the Division of Urologic Oncology.
Dr. Sklar has participated in numerous clinical trials. He has been awarded the title of “Innovator in Urology,” and has numerous publications as well as over 150 invited presentations. Dr. Sklar serves on the editorial board of the International Journal of Impotence Research and also serves as a reviewer for the Journal of Urology, World Journal of Urology, Urology, and the Asian Journal of Andrology.
Dr. Sklar is a leading physician in Maryland and has been recognized as a Top Doctor by Baltimore magazine and by Annapolis magazine numerous times. He has also been selected as a “Super Doctor” by his peers in the Washington Post magazine.